NephroBlog: Pruritus and Hemodialysis
Patients with end-stage kidney disease on hemodialysis can have many different symptoms that affect their quality of life. While seeing patients in the dialysis unit, I often see many similar symptom complaints from patients. Complaints from patients on hemodialysis include post-dialysis fatigue (need to take a nap after dialysis, no energy to run errands, etc.), muscle cramps (at night, right after dialysis), and pruritus. Pruritus is the medical term for itchy skin that can affect the quality of life of a person. The pathophysiology of chronic kidney disease-associated pruritus (also known as hemodialysis-associated pruritus or uremic pruritus) is thought to be multifactorial: a combination of demographic, biologic, neuropathic, and psychogenic factors. One theory suggest interleukin-1 as a biological causes of pruritus. The pruritus is often worse at night and affects sleep quality in these patients.
Daraghmeh et al. published a cross-sectional study examining pruritus and sleep problems among hemodialysis patients in four different centers in Palestine. Using the 5-D itching score for pruritis and the Pittsburgh Sleep Quality Index (PSQI) score for sleep disturbances. Of the 250 participants, there were 121 with complaints of pruritus and 21% patients with severe symptoms. About 66% were classified as poor sleepers on the PSQI. Regression analysis showed that the 5-D itching score and the total number of comorbidities were significantly associated with the PSQI score, demonstrating that poor sleep quality is often due to pruritus.
A prior publication by Orasan et al. found that pruritus and poor sleep quality can significantly affect survival in this population. Survival differences were found in the 170 patients treated with hemodialysis or hemodiafiltration subdivided as having both pruritus/insomnia, pruritus alone, insomnia alone, or neither symptom. Survival at 20 months was lower in those patients with both pruritus and insomnia, highlighting that these symptoms are beyond a minor annoyance.
Takahashi et al. reported on development of a treatment algorithm using topical medications for pruritus that has shown effective results. The proportion of patients with pruritus decreased significantly from 96.6% in 2009 to 66.8% in 2018 with the use of this algorithm. The algorithm consisted of treatment with moisturizers alone; moisturizer and topical steroids; moisturizer, topical steroids and Nalfurafine; and moisturizer and Nalfurafine. Nalfurafine, which can be intravenous or orally administered, is a kappa opioid receptor agonist but unfortunately it is not available in the all countries. A newer agent, Difelikefalin, also a kappa opioid receptor agonist is showing promise. This medication is administered into the venous line of the dialysis circuit at each hemodialysis session.
Use of moisturizers applied several times a day is an important part of pruritus treatment. If there is no relief, adding a topical steroid or the addition of antihistamines, or agents to address neuropathy such as gabapentin or pregabalin are potential next steps. With the emergence of new medications like Difelikefalin this opens the door to some potentially better treatment algorithms.
The incessant itching does not just effect our patient’s quality of life but also their risk of survival. What is your treatment algorithm for chronic kidney disease-associated pruritus?
- Dr. Daphne Knicely
BMC Nephrology
Follow the Topic
-
BMC Nephrology
This is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of kidney and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
Related Collections
With collections, you can get published faster and increase your visibility.
Lifestyle modifications for preventing kidney disease
BMC Nephrology invites new submissions on Lifestyle modifications for preventing kidney disease.
Chronic kidney disease (CKD) is a significant public health challenge, with lifestyle factors playing a crucial role in its prevention and management. Lifestyle modifications, including dietary changes, physical activity, weight management, and smoking cessation, have been identified as important strategies for reducing the risk of kidney disease and slowing its progression. Research in this area has highlighted the impact of lifestyle interventions on kidney health, emphasizing the potential for preventive measures to alleviate the burden of CKD.
Recent advances demonstrate the effectiveness of lifestyle interventions in reducing the risk of CKD and improving outcomes for individuals with kidney disease. Additionally, research has underscored the importance of multidisciplinary approaches that integrate lifestyle modifications into routine clinical care, promoting holistic kidney health.
Looking ahead, continued research in this area holds the potential for identifying personalized lifestyle interventions tailored to individual risk factors and cultural contexts. Furthermore, ongoing research efforts may lead to the development of innovative digital health tools and mobile applications that support individuals in adopting and sustaining healthy lifestyle behaviors to prevent kidney disease.
Topics of interest include, but are not limited to:
- Dietary interventions for kidney disease prevention
- Exercise and physical activity in CKD management
- Smoking cessation and its impact on kidney health
- Lifestyle modifications for reducing blood pressure and preventing CKD
- The role of mindfulness and stress reduction techniques in preventing kidney disease
- Impact of sleep quality and duration on kidney health
- Evaluating the effectiveness of community-based lifestyle interventions in preventing CKD
- Exploring the influence of socioeconomic factors on lifestyle modifications and kidney disease prevention
This Collection supports and amplifies research related to SDG 3: Good Health and Wellbeing.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Dec 12, 2025
Pediatric chronic kidney disease: Transitioning into adult care
BMC Nephrology invites submissions to the collection exploring various aspects of this transition from childhood to adulthood including but not limited to:
Transitional care models: Exploring effective strategies
RISE to Transition program: Evaluating its impact
Pediatric to adult services integration: Challenges and solutions
Disease awareness among adolescents with CKD: Bridging gaps
Health-related quality of life in transitioning patients: Assessments and interventions
Enhancing self-management skills in young adults with CKD
Optimizing adult CKD services for transitional patients
Pediatric nephrology: Setting the stage for successful transitions
Multidisciplinary approaches to CKD transitional care
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Aug 12, 2025
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in